249 558

Cited 2 times in

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

DC Field Value Language
dc.contributor.author박지혜-
dc.contributor.author천재희-
dc.date.accessioned2018-07-20T07:41:31Z-
dc.date.available2018-07-20T07:41:31Z-
dc.date.issued2017-
dc.identifier.issn1598-9100-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160426-
dc.description.statementOfResponsibilityopen-
dc.languageKorean, English-
dc.publisherTaehan Chang Yŏngu Hakhoe-
dc.relation.isPartOfINTESTINAL RESEARCH-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleCould adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Internal Medicine-
dc.contributor.googleauthorJihye Park-
dc.contributor.googleauthorJae Hee Cheon-
dc.identifier.doi10.5217/ir.2017.15.3.263-
dc.contributor.localIdA04575-
dc.contributor.localIdA04030-
dc.relation.journalcodeJ01182-
dc.identifier.eissn1598-9100-
dc.identifier.pmid28670224-
dc.contributor.alternativeNamePark, Ji Hye-
dc.contributor.alternativeNameCheon, Jae Hee-
dc.contributor.affiliatedAuthorPark, Ji Hye-
dc.contributor.affiliatedAuthorCheon, Jae Hee-
dc.citation.volume15-
dc.citation.number3-
dc.citation.startPage263-
dc.citation.endPage265-
dc.identifier.bibliographicCitationINTESTINAL RESEARCH, Vol.15(3) : 263-265, 2017-
dc.identifier.rimsid39805-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.